Quality of life associated with treatment adherence in patients with type 2 diabetes: A cross-sectional study

BMC Health Services Research

Volumn 8, Issue , 2008, Pages

  Martínez, Yolanda V ^a   Prado Aguilar, Carlos A ^a   Rascón Pacheco, Ramón A ^a   Valdivia Martínez, José J ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETIC PATIENT; FEMALE; HEALTH CENTER; HUMAN; KNOWLEDGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PILL; PRESCRIPTION; QUALITY OF LIFE; QUESTIONNAIRE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; MEXICO; MIDDLE AGED; NONPARAMETRIC TEST; SOCIOECONOMICS; STATISTICAL MODEL;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LINEAR MODELS; MALE; MEXICO; MIDDLE AGED; PATIENT COMPLIANCE; QUALITY OF LIFE; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC;

EID: 50249177139     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-8-164     Document Type: Article

References (50)

1. On white-coat effects and the electronic monitoring of compliance. AR Feinstein, Arch Intern Med 1990 150 1377 1378 10.1001/archinte.150.7.1377 2369237
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (ukpds 33). UKPDS, Lancet 1998 352 837 853 10.1016/S0140-6736(98)07019- 6 9742976
3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (ukpds 34). UKPDS, Lancet 1998 352 854 865 10.1016/S0140-6736(98)07037-8 9742977
4. Drug-related problems causing admission to a medical clinic. U Bergman BE Wilholm, European Journal of Clinical Pharmacology 1981 20 193 200 10.1007/BF00544597 7286037
5. A systematic review of adherence with medications for diabetes. JA Cramer, Diabetes Care 2004 27 5 1218 1224 10.2337/diacare.27.5.1218 15111553
6. Assessment of sulfonylurea adherence and metabolic control. BJ Mason JR Matsuyama SG Jue, Diabetes Educator 1995 21 1 52 57 10.1177/014572179502100109 7835205
7. Validation of the United States' version of the World Health Organization Quality of Life (WHOQOL) instrument. AE Bonomi DL Patrick DM Bushnell M Martin, Journal of Clinical Epidemiology 2000 53 19 23 10.1016/S0895-4356(99)00121-3 10693899
8. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.[see comment]. MA Testa DC Simonson, JAMA 1998 280 17 1490 1496 10.1001/jama.280.17.1490 9809729
9. Psychometric properties of the World Health Organisation quality of life questionnaire (WHOQOL-100) in diabetic patients in Croatia. M Pibernik-Okanovi, Diabetes Research & Clinical Practice 2001 51 2 133 143 10.1016/S0168- 8227(00)00230-8
10. Association between glycaemic control and quality of life in diabetes mellitus. CY Lau AK Qureshi SG Scott, J Postgrad Med 2004 50 3 189 93; discussion 194 15377803
11. The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. M Weinberger MS Kirkman GP Samsa PA Cowper EA Shortliffe DL Simel JR Feussner, Med Care 1994 32 12 1173 1181 10.1097/00005650-199412000-00002 7967857
12. Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control. PP Goddijn HJ Bilo EJ Feskens KH Groeniert KI van der Zee B Meyboom-de Jong, Diabetic Medicine 1999 16 1 23 30 10.1046/j.1464-5491.1999.00002.x 10229289
13. Cross- sectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2). N Kleefstra LJ Ubink - Veltmaat ST Houweling KH Groenier B Meyboom- de Jong HJ Bilo, Neth J Med 2005 63 6 251 221 16011013
14. Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus. S Pitale D Kernan-Schroeder N Emanuele C Sawin J Sacks C Abraira, J Diabetes Complications 2005 19 4 207 211 10.1016/j.jdiacomp.2004.12.002 15993354
15. Interrelationships of quality of life, compliance, clinical outcomes and life satisfaction: a cross-sectional study on hypertensive geriatrics. RS Pippalla V Chinburapa R Duval RS Akula, Journal of Clinical Pharmacy and Therapeutics 1997 22 5 357-369 10.1046/j.1365-2710.1997.00116.x
16. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. JC Sung MB Nichol F Venturini KL Bailey JS McCombs Cody, Am J Manag Care 1998 4 10 1421 1430 10338735
17. Predictors of self-reported adherence in persons living with HIV disease. WL Holzemer IB Corless KM Nokes JG Turner MA Brown GM Powell-Cope J Inouye SB Henry PK Nicholas CJ Portillo, AIDS Patient Care & Stds 1999 13 3 185 197 10375267
18. The relationship between dug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. SJ Billups DC Malone BL Carter, Pharmacotherapy 2000 20 8 941 949 10.1592/phco.20.11.941.35266 10939555
19. Is adherence to drug treatment correlated with health-related quality of life? I Cote K Farris D Feeny, Quality of Life Research 2003 12 6 621 633 10.1023/A:1025180524614 14516172
20. Measuring Quality of Life. GROUP WHOQOL, Geneva, World Health Organization 1997 1 13
21. Determinants of compliance: The disease and the mechanics of treatment. RB Haynes, Adherence to Long-Term Therapies Evidence For Action World Health Organisation, Press JHU, 1979 3
22. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. CS Rand, Adherence to Long-Term Therapies: Evidence for Action World Health Organisation 1993 68D 74D
23. Adherence to Long-Term Therapies. Evidence For Action. WHO, World Health Organisation 2003 3 4
24. Compliance: the dilemma of the chronically ill. KE Gerber AM Nehemkis, Nwe York, Springer Publishing Company, Inc. 1986
25. Attitudes and the attitude-behavior relation: Reasoned and automatic processes. I Ajzen M Fishbein, European Review of Social Psychology 2000 11 1-34
26. Concurrent and predictive validity of a self-reported measure of medication adherence. DE Morisky LW Green DM Levine, Med Care 1986 24 1 67 74 10.1097/00005650-198601000-00007 3945130
27. Clinical Epidemiology: a Basic Science for Clinical Medicine. DL Sackett RB Haynes GH Guyatt P Tugwell, Boston, Little, Brown and Company 2nd 1991
28. Clinical Epidemiology. The Essentials. RH Fletcher SW Fletcher EH Wagner, Maryland, USA, Williams & Wilkins 1996 67 71
29. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. GROUP WHOQOL, Soc Sci Med 1995 41 10 1403 1409 10.1016/0277-9536(95)00112-K 8560308
30. Psychometric properties of the WHO Quality of life questionnaire (WHOQOL-100) in patients with chronic diseases and their caregivers in China. LI Lingjiang Y Derson X Shuiyuan al, Bull World Health Organ 2004 82 7 493 502 15508194
31. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. G WHOQOL M Power W Kuyken J Orley, Soc Sci Med 1998 46 12 1569 1585 10.1016/S0277-9536(98)00009-4 9672396
32. Stata Statistical Software: Release 9.0. S Corporation, Collage Station, TX 2005
33. Phamacological therapy compliance in diabetes. BR Duran-Varela B Rivera-Chavira E Franco-Gallegos, Salud Publica Mex 2001 43 3 233 236 11452700
34. Factors associated with therapy noncompliance in type-2 diabetes patients. L Hernandez-Ronquillo JF Tellez-Zenteno J Garduno-Espinosa E Gonzalez-Acevez, Salud Publica Mex 2003 45 3 191 197 12870420
35. Time to stop counting the tablets? T Pullar S Kumar H Tindall M Feely, Clin Pharmacol Ther 1989 46 2 163 168 2758726
36. Validity of three different methods to measure treatment adherente in type 2 diabetics. YV Martinez CA Prado-Aguilar RA Rascon-Pacheco Y Segovia-Bernal, XV National Meeting of Health Research Oaxtepec, Morelos, Mexico, Mexican Institute of Social Security 2006
37. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. PT Donnan TM MacDonald AD Morris, Diabet Med 2002 19 4 279 284 10.1046/j.1464-5491.2002. 00689.x 11942998
38. Assessing medication adherence in the elderly: which tools to use in clinical practice? EJ MacLaughlin CL Raehl AK Treadway TL Sterling DP Zoller CA Bond, Drugs Aging 2005 22 3 231 255 10.2165/00002512-200522030-00005 15813656
39. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. PS Ciechanowski WJ Katon JE Russo, Arch Intern Med 2000 160 21 3278 3285 10.1001/archinte.160.21.3278 11088090
40. Espiritualidad y religiosidad en adultos mayores mexicanos. A Rivera-Ledesma M Montero, Salud Mental 2005 28 6 51 58
41. Instituto Nacional de Estadistica Geografia e Informatica: XII Censo Nacional de Población y Vivienda. INEGI, Mexico 2000
42. Uncertainty, spiritual well-being, and psychosocial adjustment to chronic illness. BJ Landis, Issues Ment Health Nurs 1996 17 3 217 231 10.3109/01612849609049916 8707542
43. Correlates of health-related quality of life in overweight and obese adults with type 2 diabetes. WJ Rejeski W Lang RH Neiberg B Van Dorsten GD Foster ML Maciejewski R Rubin DF Williamson, Obesity (Silver Spring) 2006 14 5 870 883 10.1038/oby.2006.101 16855197
44. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care 1999 22 7 1125 1136 10.2337/diacare.22.7.1125 10388978
45. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. WK Redekop MA Koopmanschap RP Stolk GE Rutten BH Wolffenbuttel LW Niessen, Diabetes Care 2002 25 3 458 463 10.2337/diacare.25.3. 458 11874930
46. The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. M Rose H Fliege M Hildebrandt T Schirop BF Klapp, Diabetes Care 2002 25 1 35 42 10.2337/diacare.25.1.35 11772898
47. Determinants of the quality of life among diabetic subjects in Kerala, India. RT Varghesea R Salinia P Abrahama KK Reeshmaa K Vijayakumar, Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2007 1 3 173 179 10.1016/j.dsx.2007.05.005
48. Vulnerability and social class: differential patterns of personality and social support over the social classes. AV Ranchor J Bouma R Sanderman, Pers Individ Dif 1996 20 2 229 237 10.1016/0191-8869(95)00156-5
49. The principle of congruity in the prediction of attitude change. CE Osgood PH Tannenbaum, Psychol Rev 1955 62 1 42 55 10.1037/h0048153 14357526
50. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. RR Rubin, Am J Med 2005 118 Suppl 5A 27S 34S 10.1016/j.amjmed.2005.04. 012 15850551